<DOC>
	<DOCNO>NCT02533349</DOCNO>
	<brief_summary>Based meta-analysis prokinetics trial laryngopharyngeal reflux disease ( LPRD ) ( Glicksman et al . 2014 ) , well design study perform 4 article . But , study several problem include inclusion criterion , randomization method , placebo medication . They similar result prokinetics proton pump inhibitor ( PPI ) synergistic effect management LPRD . Therefore , aim study evaluate efficacy prokinetics additional medication proton pump inhibitor well design randomize double blind case-control study .</brief_summary>
	<brief_title>Trial Proton Pump Inhibitor With Prokinetics Placebo Patients With Laryngopharyngeal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Laryngopharyngeal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Age 20 65 year Reflux Symptom Index ( RSI ) &gt; 7 , Reflux Finding Score ( RFS ) &gt; 13 Exclusion Criteria Taken proton pump inhibitor within 3months Taken steroid within 3months Pregnancy Breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>laryngopharyngeal reflux disease</keyword>
	<keyword>prokinetics</keyword>
	<keyword>proton pump inhibitor</keyword>
</DOC>